Jonas Eriksson

Jonas Eriksson is a Global Pharmacovigilance & Patient Safety Scientist at Sobi - Swedish Orphan Biovitrum AB (publ) since September 2020, with a robust background in pharmacovigilance and clinical development. Previously, Jonas held various roles at AstraZeneca from January 2003 to September 2020, including Pharmacovigilance Scientist and Senior Scientist in Pharmaceutical Sciences, where responsibilities encompassed leading analytical teams and developing clinical strategies for pipeline projects. Earlier experience includes a position at Institut national des langues in Luxembourg, where Jonas studied German and French, and a role at AstraHässle AB focused on method development for pharmaceuticals. Academic qualifications include a PhD from the University of Groningen and an MS from the University of Gothenburg, with a foundational degree in chemistry.